Participation in a patient support group increases prostate cancer patient knowledge

A newly published study from a group of German researchers examined the degree to which participation in patient support group activities increased prostate cancer patients’ health literacy and, specifically, their prostate cancer‐specific and non‐cancer‐specific knowledge about health care. … READ MORE …

New test now available for identification of AR-V7 mutations in mCRPC

According to a media release issued yesterday, Genomic Health has now made available a commercial test for risk of the AR-V7 mutation in men with metastatic, castration-resistant prostate cancer (mCRPC). … READ MORE …

Research survey on male sexuality and prostate cancer

A team of researchers at the University of Calgary in Canada is seeking men with a history of prostate cancer willing to complete a survey related to men’s sexuality. … READ MORE …

Second CureTalk discussion on living well with prostate cancer

This evening at 6:00 pm Eastern time we shall be continuing our conversation with Dr. Paul Schellhammer regarding ways to encourage patients to be able to “live well” after a diagnosis of prostate cancer. Click here to get the detailed information and join the discussion. … READ MORE …

Can phi density accurately predict risk for clinically significant prostate cancer?

A new article in BJU International has suggested the possibility that Prostate Health Index density (i.e., a patient’s phi score divided by his prostate volume) may be able to predict the probability of a finding of clinically significant prostate cancer on biopsy. … READ MORE …

How important is hanging onto your job during a recession?

There’s a new paper in an open-access journal called eCancer Medical Science that is asking a really tough question about links between unemployment and risk for prostate cancer mortality in the European Union nations. … READ MORE …

Over-use of PSA testing in men > 65 with short life expectancies?

Why is it that we seem to be so focused on testing for risk of prostate cancer in older men with life expectancies of < 10 years, i.e., men who are almost certainly at very low risk for clinically significant disease? … READ MORE …